Sepsis Epidemiology Forecast Report To 2033

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The "Sepsis: Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.
Sepsis and septic shock are life-threatening conditions with an extremely high mortality rate (Shankar-Hari et al., 2017; Dupuis et al., 2020). Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection (Singer et al., 2016; Shankar-Hari et al., 2017). Septic shock is defined as a state of acute circulatory failure characterized by persistent arterial hypotension that cannot be successfully rescued by fluid resuscitation (Singer et al., 2016; Shankar-Hari et al., 2017). A constellation of clinical, laboratory, physiologic, and microbiologic data is needed for the diagnosis of sepsis and septic shock (Singer et al., 2016).
Report Scope

• This report provides an overview of the risk factors and the global and historical epidemiological trends for sepsis and septic shock in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and China).
• Additionally, this report includes a 10-year epidemiological forecast of sepsis for men and women from 2023-33 for the following segmentations in all ages across the 8MM: diagnosed incident cases of sepsis segmented by sex and age (ages 0-28 days, 1 month-17 years, 18-64 years, and 65 years and older), diagnosed incident cases of sepsis by causative agent (Gram positive and Gram negative bacteria, fungi, and other organism), diagnosed incident cases of sepsis by organ dysfunction (acute kidney dysfunction, acute respiratory dysfunction, disseminated intravascular coagulopathy [DIC], hepatic dysfunction, and cardiovascular dysfunction), and in-hospital mortality of sepsis.
• This report also includes a 10-year epidemiological forecast of septic shock for men and women from 2023-33 for the following segmentations in all ages across the 8MM: diagnosed incident cases of septic shock segmented by sex and age (0-28 days, 1 month-17 years, 18-64 years, and 65 years and older), diagnosed incident cases of septic shock by causative agent, agent (gram positive and gram negative bacteria, fungi, and other organism) diagnosed incident cases of septic shock by organ dysfunction (acute kidney dysfunction, acute respiratory dysfunction, DIC, hepatic dysfunction, and cardiovascular dysfunction), and in-hospital mortality of septic shock.

The Sepsis Epidemiology series will allow you to:

• Develop business strategies by understanding the trends shaping and driving the global sepsis markets.
• Quantify patient populations in the global sepsis markets to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for sepsis therapeutics in each of the markets covered.
• Understand magnitude of the sepsis population by age, sex, causative agent, and organ dysfunction.

Key Topics Covered:

1. List of Contents
1.1. List of Tables
1.2. List of Figures

2. About the Analyst

3. Sepsis: Executive Summary
3.1. Catalyst
3.2. Related reports
3.3. Upcoming reports

4. Epidemiology
4.1. Disease background
4.2. Risk factors and comorbidities
4.3. Global and historical trends
4.4. 8MM forecast methodology
4.5. Epidemiological forecast for sepsis and septic shock (2023-33)
4.5.1. Diagnosed incident cases of sepsis
4.5.2. Age-specific diagnosed incident cases of sepsis
4.5.3. Sex-specific diagnosed incident cases of sepsis
4.5.4. Diagnosed incident cases of sepsis by causative agent
4.5.5. Organ dysfunction in diagnosed incident cases of sepsis
4.5.6. Sepsis in-hospital mortality cases
4.5.7. Diagnosed incident cases of septic shock
4.5.8. Age-specific diagnosed incident cases of septic shock
4.5.9. Sex-specific diagnosed incident cases of septic shock
4.5.10. Diagnosed incident cases of septic shock by causative agent
4.5.11. Organ dysfunction in diagnosed incident cases of septic shock
4.5.12. Septic shock in-hospital mortality cases
4.6. Discussion
4.6.1. Epidemiological forecast insight
4.6.2. COVID-19 impact
4.6.3. Limitations of the analysis
4.6.4. Strengths of the analysis

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

MENAFN04112024004107003653ID1108847862